Fusix Biotech Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Investors
  • 8

Fusix Biotech General Information

Description

Developer of a cancer therapy designed for commercializing a novel fusion-based oncolytic viro-immunotherapy. The company specializes in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy and focuses on research, translation, clinical development, and manufacturing, enabling the healthcare industry to provide safe and effective tumor therapy.

Contact Information

Website
www.fusixbiotech.de
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Neherstraße 1
  • 81675 Munich
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Neherstraße 1
  • 81675 Munich
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fusix Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC (Series A) 08-Apr-2026 In Progress Pre-Clinical Trials
7. Accelerator/Incubator 18-Nov-2024 Completed Pre-Clinical Trials
6. Seed Round 13-Dec-2023 Completed Pre-Clinical Trials
5. Accelerator/Incubator 23-Oct-2023 Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Accelerator/Incubator Completed Pre-Clinical Trials
1. University Spin-Out 30-Mar-2022 Completed Pre-Clinical Trials
To view Fusix Biotech’s complete valuation and funding history, request access »

Fusix Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fusix Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
BlueYard Capital Venture Capital Minority
Nucleate Accelerator/Incubator
Gold Track Accelerator/Incubator
Technical University of Munich University
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Fusix Biotech FAQs

  • When was Fusix Biotech founded?

    Fusix Biotech was founded in 2022.

  • Where is Fusix Biotech headquartered?

    Fusix Biotech is headquartered in Munich, Germany.

  • What is the size of Fusix Biotech?

    Fusix Biotech has 3 total employees.

  • What industry is Fusix Biotech in?

    Fusix Biotech’s primary industry is Drug Discovery.

  • Is Fusix Biotech a private or public company?

    Fusix Biotech is a Private company.

  • What is Fusix Biotech’s current revenue?

    The current revenue for Fusix Biotech is .

  • Who are Fusix Biotech’s investors?

    EIT Health, BlueYard Capital, Nucleate, Gold Track, and Technical University of Munich are 5 of 8 investors who have invested in Fusix Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process